wire

« BACK

Pharmacology



Results 1 - 50 of 392.
1 2 3 4 5 8 Next »


Health - Pharmacology - 18.06.2021
COVID: The three barriers that stop people being vaccinated
Getting everyone in a country vaccinated is like watching software updates load: it whizzes along for the first 80% or so and then seems to take forever to finish the rest.

Health - Pharmacology - 17.06.2021
A low-cost life support machine for patients with covid
A low-cost life support machine for patients with covid
A device that helps desperately sick patients breathe- and- costs around Ā£150 to manufacture- could revolutionise access -to life-saving care in low to middle income countries.

Health - Pharmacology - 16.06.2021
RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own. The treatment uses a combination of two monoclonal antibodies (casirivimab and imdevimab, known as REGEN-COV in the US) that bind specifically to two different sites on the coronavirus spike protein, neutralising the ability of the virus to infect cells.

Health - Pharmacology - 16.06.2021
Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%
A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

Health - Pharmacology - 16.06.2021
GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic
GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic
New alliance brings together academic expertise looking at all aspects of antimicrobial resistance from public health to agriculture.

Health - Pharmacology - 15.06.2021
Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease | University of Oxford
A new study led by the Nuffield Department of Population Health at the will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Campus - Pharmacology - 15.06.2021

Health - Pharmacology - 09.06.2021
Averting an antibiotics apocalypse: major funding announced to tackle resistance to antibiotics
Averting an antibiotics apocalypse: major funding announced to tackle resistance to antibiotics
A cross-disciplinary team from the Universities of Oxford, Ulster and UCL today announced major funding from EPSRC, part of UK Research and Innovation (UKRI), to tackle the growing challenge of Antimicrobial Resistance (AMR).

Health - Pharmacology - 09.06.2021
Novel UCL developed cancer drug to be trialled in humans
Patients with a number of Non-Hodgkin lymphoma (NHL) subtypes will be used to trial a novel cancer treatment developed by researchers at UCL, which holds "great promise" for several incurable conditions.

Health - Pharmacology - 08.06.2021
RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19
RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19.

Health - Pharmacology - 07.06.2021
Alternative treatments to combat drug-resistant bacteria focus of major new study
Alternative treatments to combat drug-resistant bacteria focus of major new study
The growing challenge of Antimicrobial Resistance (AMR), where germs like bacteria and fungi develop the ability to defeat the drugs designed to kill them, is at the heart of a new funding collaboration involving UCL researchers.

Health - Pharmacology - 04.06.2021
Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant
Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are, on average, lower than those against variants previously circulating in the UK, finds a new study involving UCL.

Health - Pharmacology - 01.06.2021
Immunity experts move into state-of-the-art facilities
Immunity experts move into state-of-the-art facilities
Scientists at UCL are preparing to move into a new ultra-modern research facility which will enable them to work more closely with clinicians to develop revolutionary treatments and cures for some of the most devastating diseases of the immune system.

Health - Pharmacology - 26.05.2021
Almost half of patients with inoperable pancreatic cancer are not prescribed essential medication
A University of Birmingham-led study has found almost half of people diagnosed within inoperable pancreatic cancer are not prescribed inexpensive yet essential tablets without which they cannot digest food - placing them at risk of starvation or being less able to tolerate treatment.

Life Sciences - Pharmacology - 26.05.2021
Covid-19 vaccine: Common stroke symptoms must be ’urgently evaluated’
UCL and UCLH neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.

Health - Pharmacology - 19.05.2021

Pharmacology - Health - 14.05.2021
Clinical trial co-led by UCL leads to new bowel cancer drug approval
Clinical trial co-led by UCL leads to new bowel cancer drug approval
Cancer researchers at UCL, involved in an international trial which found that pembrolizumab more than doubled the 'progression free survival' of patients with a subtype of bowel cancer, when compared with chemotherapy, are delighted it has now been approved by the UK regulator.

Health - Pharmacology - 14.05.2021
Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people, finds study
Antibody response in people aged over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer COVID-19 vaccine after 12 weeks compared to those who have it at a three-week interval, finds a new study led by the University of Birmingham in collaboration with Public Health England.

Pharmacology - Health - 12.05.2021
Personalised pacemakers could help heart patients keep fit
Personalised pacemakers could help heart patients keep fit
People living with heart failure could benefit from personalised pacemakers to help them exercise safely, thanks to a trial being carried out by a team in the School of Medicine.

Health - Pharmacology - 11.05.2021
Better treatment for miscarriage patients is more cost effective than current standard NHS treatment
A new drug combination that is better at treating miscarriage is also more cost effective than current standard NHS treatment, finds a new study led by the University of Birmingham and Tommy's National Centre for Miscarriage Research. A previous study by the same team and published in The Lancet in August last year, found that a combined drug treatment is more effective than the standard medication for women having miscarriages without symptoms - also known as missed, delayed or silent miscarriage.

Health - Pharmacology - 11.05.2021
Study launches to investigate immune response to SARS-CoV-2 infection in patients with antibody deficiencies
A new study being led by the University of Birmingham, University Hospitals Birmingham NHS Foundation Trust, and University College London aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.

Health - Pharmacology - 11.05.2021

Health - Pharmacology - 11.05.2021
Study investigates immune response to Covid-19 in patients with antibody deficiency
Study investigates immune response to Covid-19 in patients with antibody deficiency
How the immune systems of patients with antibody deficiency respond to SARS-CoV-2 infection and vaccination will be investigated as part of a new national study co-led by UCL researchers.

Health - Pharmacology - 10.05.2021
Bayer to invest in childhood cancer trial at the University of Birmingham
Significant funding from Bayer, a global enterprise with core competencies in the life science fields of healthcare and nutrition, is enabling the University of Birmingham's Cancer Research UK Clinic

Health - Pharmacology - 06.05.2021
University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb
The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.

Pharmacology - Health - 06.05.2021
Only 41% of people would sign up for COVID-19 trials says new report by the University of Birmingham
Only 41% of people would sign up for COVID-19 trials says new report by the University of Birmingham
Research conducted by the University of Birmingham shows in order to have an effective Covid-19 vaccination rollout it has to be widely accepted to the entire population.

Pharmacology - Health - 05.05.2021
To radically improve the delivery of chemotherapy treatment
To radically improve the delivery of chemotherapy treatment
New scheduling model improves patient waiting times by 80% and cuts nurse overtime by more than 30% Last updated on Thursday 6 May 2021 A new study from the University of Bath School of Management, T

Pharmacology - Health - 28.04.2021
Preference for AZ vaccine declines - but vaccine confidence undented
The public's preference for the AstraZeneca Covid vaccine has declined since last month, and belief that it causes blood clots has increased - but despite this, vaccine confidence is higher than it w

Pharmacology - Social Sciences - 19.04.2021
Researchers win £1.3M funding to make a portable device to detect street drug ’spice’
A portable device to detect spice is being developed at Bath. This will be the first gadget to give on-the-spot readings for the street drug.

Health - Pharmacology - 16.04.2021

Health - Pharmacology - 15.04.2021
Risk of rare blood clotting higher for COVID-19 than for vaccines
COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Health - Pharmacology - 14.04.2021
Over-80s show similar antibody responses following single vaccination with either Pfizer or AstraZeneca vaccine - but cellular responses are enhanced after AstraZeneca vaccine
People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.

Health - Pharmacology - 14.04.2021
Profile: How UK doctor linked rare blood-clotting to AstraZeneca Covid jab
Professor Marie Scully (UCL Cardiovascular Science) is interviewed about her about her work identifying a new rare blood clotting syndrome linked to the AstraZeneca Covid-19 vaccine & established the correct test & treatments for patients, helping save lives.

Health - Pharmacology - 13.04.2021
COVID-19 drug screening hub at the University of Glasgow begins work
A new COVID-19 drug screening and resistance hub in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR), has begun its vital work.

Health - Pharmacology - 13.04.2021
Newly launched British biotech company pioneers ground-breaking potential treatments for COVID-19
Newly launched British biotech company pioneers ground-breaking potential treatments for COVID-19
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for coronavirus.

Health - Pharmacology - 13.04.2021
Artificial Intelligence used to automate assessment of Mesothelioma
Patients receiving treatment for the "asbestos cancer", Mesothelioma, are being assessed with Artificial Intelligence (AI) as part of a prototype imaging system which could revolutionise the way people with the disease are cared for.

Health - Pharmacology - 12.04.2021
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1,779 participants.

Health - Pharmacology - 12.04.2021
Weather forecasts that predict meningitis outbreaks
Weather forecasts that predict meningitis outbreaks
Scientists are using weather forecasts to predict the location and scale of impending meningitis outbreaks in sub-Saharan Africa. It is part of an early-warning system being piloted with the aim of giving health agencies more time to activate emergency response plans.

Pharmacology - 09.04.2021

Health - Pharmacology - 07.04.2021
Opinion: The risks of the AstraZeneca jab are so small, yet the gains are so great
Research into the potential link between the AstraZeneca Covid-19 vaccine and blood clots is urgently needed, but the benefits of the vaccine far outweigh the risks even if a causal link is established, says Professor David Werring (UCL Queen Square Institute of Neurology).

Health - Pharmacology - 01.04.2021
Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response. The research involved 100 people aged 80 to 96, who were living independently, and had received the Pfizer vaccine twice at three weeks apart.
1 2 3 4 5 8 Next »